News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,365 Results
Type
Article (39166)
Company Profile (282)
Press Release (648917)
Section
Business (203910)
Career Advice (1998)
Deals (35374)
Drug Delivery (89)
Drug Development (80858)
Employer Resources (168)
FDA (16103)
Job Trends (14812)
News (344662)
Policy (32450)
Tag
Academia (2530)
Alliances (49194)
Alzheimer's disease (1266)
Approvals (16067)
Artificial intelligence (146)
Bankruptcy (354)
Best Places to Work (11583)
Biotechnology (199)
Breast cancer (191)
Cancer (1396)
Cardiovascular disease (112)
Career advice (1665)
Cell therapy (285)
Clinical research (64739)
Collaboration (489)
Compensation (281)
COVID-19 (2542)
C-suite (109)
Data (1398)
Diabetes (178)
Diagnostics (6171)
Earnings (84909)
Employer resources (146)
Events (110106)
Executive appointments (409)
FDA (16805)
Funding (443)
Gene therapy (200)
GLP-1 (601)
Government (4333)
Healthcare (18709)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16357)
Job creations (3626)
Job search strategy (1418)
Layoffs (420)
Legal (7864)
Lung cancer (203)
Lymphoma (99)
Manufacturing (209)
Medical device (13215)
Medtech (13220)
Mergers & acquisitions (19211)
Metabolic disorders (463)
Neuroscience (1590)
NextGen Class of 2024 (6499)
Non-profit (4467)
Northern California (1729)
Obesity (263)
Opinion (184)
Patents (123)
People (56485)
Phase I (20136)
Phase II (28510)
Phase III (21254)
Pipeline (518)
Postmarket research (2560)
Preclinical (8546)
Radiopharmaceuticals (236)
Rare diseases (266)
Real estate (5892)
Regulatory (21703)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1492)
Startups (3562)
United States (15471)
Vaccines (565)
Weight loss (183)
Date
Today (125)
Last 7 days (245)
Last 30 days (1724)
Last 365 days (34618)
2025 (215)
2024 (35253)
2023 (40077)
2022 (51173)
2021 (55711)
2020 (54086)
2019 (46543)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (713)
Arizona (197)
Asia (37309)
Australia (6092)
California (3903)
Canada (1483)
China (328)
Colorado (174)
Connecticut (181)
Europe (79872)
Florida (553)
Georgia (137)
Illinois (391)
Indiana (228)
Maryland (645)
Massachusetts (3013)
Michigan (176)
Minnesota (296)
New Jersey (1127)
New York (1111)
North Carolina (747)
Northern California (1729)
Ohio (148)
Pennsylvania (945)
South America (1092)
Southern California (1492)
Texas (564)
Utah (109)
Washington State (403)
688,365 Results for "diasorin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc.(Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit.
February 13, 2023
·
9 min read
Deals
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million.
February 28, 2023
·
6 min read
Policy
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
QIAGEN and DiaSorin announced that the U.S. Food and Drug Administration has approved the LIAISON® QuantiFERON®-TB Gold Plus assay for use on DiaSorin’s automated LIAISON® XS platform.
November 29, 2021
·
7 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
TheoremRx Inc. Enters into Agreement for a Proposed Transaction
January 2, 2025
·
1 min read
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
January 6, 2025
·
5 min read
1 of 68,837
Next
